Walmart to Replace Astrazeneca on Nasdaq-100 on Jan. 20

MarketsA Walmart worker in a holiday costume gathers shopping carts in the parking area of a Walmart Supercenter store in Monroe, New York, U.S., December 9, 2025. Mike Segar/ReutersReuters1/11/2026|Updated: 1/12/20260:00Walmart will replace British drugmaker AstraZeneca in the Nasdaq-100 Index on January 20, the exchange operator said on Friday.The retail giant said in November it would shift its longtime listing on the New York Stock Exchange to its main rival.ReutersAuthorAuthor’s Selected ArticlesEPA to Reassess Safety of Herbicide ParaquatJan 12, 2026Bessent Says Australia, India Invited to G7 Meeting on Critical MineralsJan 11, 2026Death Toll in Philippines Landfill Collapse Rises to 4Jan 11, 2026Following Venezuela, Nicaragua Releases Prisoners After US DemandsJan 11, 2026